2017 ASCO Annual Meeting
Posted: June 2017 By Erik J. MacLaren, PhD The Annual Meeting of the American Society of Clinical Oncology (ASCO) is taking place June 2–6 in Chicago, Illinois, and over 5,000 […] Read more
Posted: June 2017 FDA Warns of Fraudulent Cancer Drugs On April 25, 2017, the US Food and Drug Administration (FDA) issued warning letters to 14 companies regarding more than 65 […] Read more
Posted: June 2017 By Νiki Karachaliou, MD, PhD The identification of oncogenic driver alterations in non-small cell lung cancer (NSCLC), such as EGFR mutations and ALK rearrangements, each of which […] Read more
Posted: June 2017 By Cynthia L. Kryder, MS Decades of immunology research have shown that it is possible to harness the power of the immune system to fight cancer. In […] Read more
Posted: June 2017 By Bernard Milleron, MD, and Sébastien Couraud, MD, PhD Large-scale lung cancer screening trials have been successfully conducted in several countries, and formal screening recommendations have been […] Read more
Posted: June 2017 By John K. Field, PhD, FRCPath and James L. Mulshine, MD, PhD There is now robust and consistent evidence for the cost-effectiveness of lung cancer computed tomography […] Read more
Posted: June 2017 Long-term IASLC member Bruce E. Johnson, MD, will serve as the 2017– 2018 President of the American Society of Clinical Oncology (ASCO) upon the conclusion of the […] Read more